Emtricitabine/Tenofovir Disoproxil Mylan

Emtricitabine/Tenofovir Disoproxil Mylan is a combination medication used for HIV treatment and prevention. This oral antiretroviral therapy helps manage HIV infection and reduce transmission risk.

Emtricitabine/Tenofovir Disoproxil Mylan is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals. This medication works by reducing the amount of HIV in the body, helping to control the infection and improve the immune system.

Common effects of Emtricitabine/Tenofovir Disoproxil Mylan may include headache, nausea, diarrhea, and fatigue. Some individuals may experience dizziness or rash. These effects vary among users and are not experienced by everyone taking the medication.

Emtricitabine/Tenofovir Disoproxil Mylan should be used with caution in individuals with kidney problems or bone disorders. Regular monitoring of kidney function and bone density is recommended. Always follow the advice of a healthcare professional regarding the use of this medication.

Emtricitabine/Tenofovir Disoproxil Mylan may interact with other medications, including those used to treat HIV, hepatitis B, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.